Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro can be taken up to four days after your usual injection day without losing its place in your schedule — so if Monday slips to Thursday, you are still within the window described in the prescribing information. The key is that once you have taken the delayed dose, your next injection should be at least four days later, and you then reset to a new weekly day. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses your suitability before treatment begins, and any persistent uncertainty about timing should go to that clinician or your Patient Information Leaflet rather than a general guide like this one.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the scenario: your usual Mounjaro day was Monday, life got in the way, and it is now Friday afternoon. Four days have passed. This is the boundary the Mounjaro Summary of Product Characteristics on the eMC describes, if the missed dose is within four days of when it was due, you can take it and then set a new weekly day from that injection. If more than four days have passed, the guidance says to leave that dose entirely and resume on your next planned day.
That four-day window matters because tirzepatide has a half-life long enough to tolerate modest timing shifts without a significant gap in coverage. It does not, however, mean you can drift freely from week to week. A consistent day keeps the medicine working as smoothly as the clinical trials showed it can. The NHS medicines page for tirzepatide makes the same point: regularity is part of how the treatment is designed to be used.
One practical habit that takes under a minute: set a recurring calendar alert on your phone for the same day and time each week, with a second reminder two hours earlier as a prompt. Patients who do this rarely find themselves in the four-day-window question at all.
The instinct when you realise you are late is to wonder whether taking tonight's dose and then your usual dose in a couple of days evens things out. It does not. Two doses in quick succession roughly double your exposure to the medicine in a short period, and the most likely result is a sharper wave of gastrointestinal side effects (nausea, vomiting, stomach discomfort) that the slow titration schedule exists specifically to prevent.
The titration schedule itself is worth understanding in this context. Treatment begins at a low starter dose designed to let your system adjust gradually; the therapeutic effect builds across weeks, not days. A single delayed injection, handled correctly, does not undo that build-up. Two doses at once creates a spike that can set tolerance back and make the next few days genuinely uncomfortable. For more detail on what changes when you are just a day late, or on the question of two days' delay specifically, those pages go into the same guidance in more granular steps.
If you are unsure whether the four-day window has passed, count carefully: day one is the day the dose was due, not the day you noticed you had missed it.
Three and four days late sit inside the window, but they are worth treating with a little more care. After a dose that late, the gap before your next injection needs to be at least four days, which means your new weekly day will shift noticeably from where it started. That is fine, and it is far preferable to skipping entirely if you are still within the window.
For situations where timing has gone further than four days, the three-day scenario and the four-day scenario are covered in their own pages. There is also a fuller summary of how many days late you can take Mounjaro that maps the entire window in one place, useful if you want a clear reference to save.
One thing worth noting: if your weekly day has drifted several times over a few months, it is worth a conversation with whoever prescribes your treatment. Persistent drift can be a sign that the injection day you originally chose does not fit your routine, and switching to a more reliable day is a straightforward change a prescriber can guide you through.
The four-day rule is a useful guide, but it is not a substitute for clinical input in every scenario. If you have missed multiple doses in a row, if you are at a higher dose and concerned about tolerability after a gap, or if anything about your health has changed since your last injection, your prescriber is the right person to speak to before you resume. This matters particularly at higher doses, the question of whether Mounjaro remains appropriate for you is one a prescriber reviews at each stage, not something the four-day rule covers.
At nume, every repeat order goes through a same-day clinical review by a GPhC-registered prescriber, a real clinician reads your answers, not a workflow system. If timing questions come up during that review, they are addressed before your next pen is dispensed. Our Mounjaro treatment page explains how the process works from the first consultation onwards. For questions about the cost of treatment, our price comparison guide covers what to look for and what a legitimate private prescription typically includes. When you are ready to discuss your own situation with a prescriber, starting a free consultation is the straightforward next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.